Penumbra Inc

NYSE:PENUnited States

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Contact Information

Headquarters

One Penumbra PlaceALAMEDA, CA, United States 94502

Phone

510-748-3200

Fax

302-531-3150

Executives

Chairman of the Board, President, Chief Executive Officer

Adam Elsesser

Chief Financial Officer

Maggie Yuen

Executive Vice President, General Counsel, Secretary

Johanna Roberts

Chief Accounting Officer

Lambert Shiu

Director

Arani Bose